CXCL13 levels are elevated in patients with Waldenström macroglobulinemia, and are predictive of major response to ibrutinib. (Q43272252)
Jump to navigation
Jump to search
scientific article published on 10 August 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | CXCL13 levels are elevated in patients with Waldenström macroglobulinemia, and are predictive of major response to ibrutinib. |
scientific article published on 10 August 2017 |
Statements
CXCL13 levels are elevated in patients with Waldenström macroglobulinemia, and are predictive of major response to ibrutinib (English)
Josephine M Vos
Nickolas Tsakmaklis
Christopher J Patterson
Kirsten Meid
Jorge J Castillo
Philip Brodsky
Tomas Ganz
Steven T Pals
Marie José Kersten
Lian Xu
1 reference